期刊文献+

Dynamic Changes of Multiple Immune Cells in Chronic Hepatitis B Patients Undergoing Antiviral Treatment

Dynamic Changes of Multiple Immune Cells in Chronic Hepatitis B Patients Undergoing Antiviral Treatment
下载PDF
导出
摘要 Objective Various immune cells in patients with CHB have been demonstrated to play critical roles in HBV infection.The goal of this study is to observe changes in Thl7,Treg,Thl and B lymphocytes from peripheral blood and to evaluate immune status of CHB patients undergoing antiviral treatment.Methods Total of 49 CHB patients,19 asymptomatic carriers and 29 healthy donors were included in our present study.The frequencies of peripheral Thl7 cells(CD3^+CD4^+IL-17^+Tcells),Treg cells(CD3^+CD4^+CD25^+CD127^- T cells),Th1 cells(CD3^+CD4^+IFN^-γ T cells) and B lymphocytes in chronic hepatitis B(CHB) were analyzed by flow cytometry.Results The frequency of Th17 cells increased after treatment for 6 months,but there was no statistically significant difference of IL-17 expression between baseline and 6 months after treatment.The frequencies of Treg cells,momory B cells and total CD19^+B cells decreased after antiviral treatment.The frequencies of Thl cells and plasma cells increased after antiviral treatment.Conclusions This study highlights that the reestablishment of immune function during antiviral treatment in CHB patients,which caused by the antiviral drugs or the patients themselves.CHB patients may exhibit varied responses to these antiviral drugs.It is essential to supplement immune therapy during the antiviral treatment,but Th17 may play a limited role in inflammation during antiviral treatment,targeting Th17 therapy may not be useful for CHB treatment.More time and more experiments are critical to explain it. Objective Various immune cells in patients with CHB have been demonstrated to play critical roles in HBV infection.The goal of this study is to observe changes in Thl7,Treg,Thl and B lymphocytes from peripheral blood and to evaluate immune status of CHB patients undergoing antiviral treatment.Methods Total of 49 CHB patients,19 asymptomatic carriers and 29 healthy donors were included in our present study.The frequencies of peripheral Thl7 cells(CD3^+CD4^+IL-17^+Tcells),Treg cells(CD3^+CD4^+CD25^+CD127^- T cells),Th1 cells(CD3^+CD4^+IFN^-γ T cells) and B lymphocytes in chronic hepatitis B(CHB) were analyzed by flow cytometry.Results The frequency of Th17 cells increased after treatment for 6 months,but there was no statistically significant difference of IL-17 expression between baseline and 6 months after treatment.The frequencies of Treg cells,momory B cells and total CD19^+B cells decreased after antiviral treatment.The frequencies of Thl cells and plasma cells increased after antiviral treatment.Conclusions This study highlights that the reestablishment of immune function during antiviral treatment in CHB patients,which caused by the antiviral drugs or the patients themselves.CHB patients may exhibit varied responses to these antiviral drugs.It is essential to supplement immune therapy during the antiviral treatment,but Th17 may play a limited role in inflammation during antiviral treatment,targeting Th17 therapy may not be useful for CHB treatment.More time and more experiments are critical to explain it.
出处 《国际感染病学(电子版)》 CAS 2012年第1期39-45,共7页 Infection International(Electronic Edition)
基金 funded in full by Natural Science Foundation of China(Grant number:30872238)
关键词 Hepatitis B chronic Th17/Treg/Th1/B cells Hepatitis B,chronic Th17/Treg/Th1/B cells
  • 相关文献

参考文献18

  • 1Penna A,Del Prete G,Cavalli A,Bertoletti A D'Elios MM Sorrentino R. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B[J].Hepatology,1997.1022-1027.
  • 2Tong M J,Blatt LM,McHutchison JG,Co RL,Courad A. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics:a comparison[J].Hepatology,1997.1640-1645.
  • 3Evans HG,Gullick NJ,Kelly S,Pitzalisd C,Lord GM,Kirkham BW. In vivo activated monocytes from the site of inflammation in humans specifically promote Thl7 responses[J].Proceedings of the National Academy of Sciences(USA),2009.6232-6237.
  • 4O'Quinn DB,Palmer MT,Lee YK,Weaver CT. Emergence of the Thl7 pathway and its role in host defense[J].Advances in Immunology,2008.115-163.
  • 5Nan XP,Zhang Y,Yu HT,Li Y,Sun RL,Wang JP. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection[J].Viral Immunology,2010.63-70.
  • 6Perez-Andres M,Paiva B,Nieto WG,Caraux A,Schmitz A,Almeida J. Human peripheral blood B-cell compartments:a crossroad in B-cell traffic[J].Cytometry B Clin Cytom,2010,(Suppl l):s47-s60.
  • 7Vassilopoulos D,Rapti I,Nikolaou M,Hadziyannis E,Hadziyannis SJ. Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B[J].Journal of Viral Hepatitis,2008.817-826.
  • 8Yan Z,Tan W,Zhao W,Dan Y,Wang X,Mao Q. Regulatory polymorphisms in the IL-10 gene promoter and HBV-related acute liver failure in the Chinese population[J].Journal of Viral Hepatitis,2009.775-783.
  • 9Zhang JY,Zhang Z,Lin F,Zou ZS,Xu RN,Jin L. Interleukin-17-producing CD4(+)T cells increase with severity of liver damage in patients with chronic hepatitis B[J].Hepatology,2010.81-91.
  • 10Zhang JY,Song CH,Shi F,Zhang Z,Fu JL,Wang FS. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment[J].PLoS One,2010.e13869.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部